AQST Q1 2020 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$9M-30.7% YoY

Gross Profit

$5M58.3% margin

Operating Income

-$14M-158.1% margin

Net Income

-$17M-188.6% margin

EPS (Diluted)

$-0.49

QoQ Revenue Growth

-46.6%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$64M

Total Liabilities

$85M

Stockholders' Equity

-$21M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9M	$13M	-30.7%
Gross Profit	$5M	$9M	-44.1%
Operating Income	-$14M	-$13M	-6.0%
Net Income	-$17M	-$15M	-12.3%

Revenue Segments

Manufacture and Supply Revenue

$7M94%

License and Royalty Revenue

$426,0006%